Evidence map›Paper›PMID 40410806›Full record

ArticleJournal of experimental & clinical cancer research : CR2025

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).

Klaus Pantel, Catherine Alix-Panabières, Paul Hofman, Nikolas H Stoecklein, Yong-Jie Lu, Evi Lianidou, Patrizio Giacomini, Claudia Koch, Vincent de Jager, Zandra C Deans and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy.American journal of clinical dermatology · 2026
    Review
  3. Review
  4. Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology.Virchows Archiv : an international journal of pathology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Klaus PantelELBS, Hamburg, Germany. pantel@uke.de.
Catherine Alix-PanabièresELBS, Hamburg, Germany.
Paul HofmanIHU RespirERA, Laboratory of Clinical and Experimental Pathology, FHU OncoAge, Biobank 0033-00025, Côte d'Azur University, Nice, France.
Nikolas H StoeckleinDepartment of General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty of Heinrich-Heine University Düsseldorf, Moorenstr. 5, Düsseldorf, 40225, Germany.
Yong-Jie LuCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
Evi LianidouDepartment of Chemistry, Analysis of Circulating Tumor Cells Lab, Laboratory of Analytical Chemistry, University of Athens, Athens, Greece.
Patrizio GiacominiPrecision Medicine Unit in Senology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 8, Roma, 00168, Italy.
Claudia KochELBS, Hamburg, Germany.
Vincent de JagerDepartment of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Zandra C DeansGenomics Unit, NHS England, London, UK.
Jennifer FairleyGenQA, Nine, 9 Little France Road, Edinburgh BioquarterEdinburgh, EH16 4SA, UK.
Simon J PattonEMQN CIC, Unit 4, Enterprise House, Manchester Science Park, Pencroft Way, Manchester, M15 6SE, UK.
Rodrigo A ToledoBiomarkers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, 08035, Spain.
Ed SchuuringDepartment of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Ellen HeitzerInstitute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
An HendrixDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research,, Ghent University, Ghent, Belgium.
Franz Lennard RicklefsDepartment of Neurosurgery, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Basant Kumar ThakurDepartment of Pediatrics III, University Hospital Essen and University Duisburg, Essen, Germany.
Nikolas von BubnoffUniversity Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, 23538, Germany.
Jean-Yves PiergaDepartment of Medical Oncology, Université Paris Cité, Institut Curie, Paris, 75005, France.
Christoffer GebhardtFleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Claus Lindbjerg AndersenDepartment of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Remond FijnemanDepartment of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Núria MalatsGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO) and CIBERONC, Madrid, Spain.
Ariane HallermayrMGZ - Medizinisch Genetisches Zentrum, Munich, Germany.
Claude ChelalaCentre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
Simon A JoosseELBS, Hamburg, Germany.
Gennaro CilibertoScientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40410806
PMCPMC12100835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.